Sunday, May 7, 2017

BRIEF-Myovant Sciences announces presentation of positive Phase 2 data for Relugolix

* Myovant Sciences announces presentation of positive phase 2 data for Relugolix in women with heavy menstrual bleeding and uterine fibroids at the annual meeting of the American Congress of Obstetricians and Gynecologists

by reutersCOMPANYNEWS via Endless Supplies .Biz - News
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)